DnB Asset Management
TXG icon

DnB Asset Management’s 10x Genomics TXG Stock Holding History

DnB Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Hold
9,517
– – ﹤0.01% 933
2026
Q1 		$202K Buy
+9,517
New +$190K ﹤0.01% 1167
2022
Q2 		– Sell
-11,636
Closed -$885K – 666
2022
Q1 		$885K Buy
11,636
+427
+4% +$37.4K 0.01% 613
2021
Q4 		$1.67M Buy
11,209
+1,029
+10% +$158K 0.01% 582
2021
Q3 		$1.48M Buy
+10,180
New +$1.75M 0.01% 580

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DnB Asset Management's TXG Position: Q2 2026 in Review

DnB Asset Management held its 10x Genomics (TXG) position steady in Q2 2026 at 9,517 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #933.

DnB Asset Management first reported a position in TXG in Q3 2021 and has held it in 5 quarters since. The position peaked at $1.67M in Q4 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • DnB Asset Management held 9,517 shares of 10x Genomics worth $365K as of Q2 2026.
  • DnB Asset Management left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #933 holding.
  • DnB Asset Management first reported a position in 10x Genomics in Q3 2021 and has held it in 5 quarters since.
  • DnB Asset Management's 10x Genomics position peaked at $1.67M in Q4 2021.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.